11 results on '"Kropff M"'
Search Results
2. OPTIMUM Trial: Randomized Comparison of Thalidomide Versus Dexamethasone for Relapsed Myeloma: A404
3. VMP Results in Fewer Bone Events and Greater ALP Increases Versus MP in the VISTA Study in Front-Line MM: A246
4. A Prolonged Therapy Improves Quality of Response, and CR Associated with Superior Outcomes, with VMP: A235
5. Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA: A232
6. Bortezomib and Melphalan as Part of VMP Are Associated with Similar Hematologic Toxicity to MP Alone: A220
7. Erythropoiesis-Stimulating Agents: No Impact on Long-Term Outcome in MM Patients in the VISTA Trial: A217
8. Peripheral Neuropathy with VMP Resolves in the Majority of Patients and Shows a Rate Plateau: A172
9. VMP in Renally Impaired Newly Diagnosed MM Patients: Cohort Analysis of the VISTA Study: A166
10. Similar Benefit in Patients Aged ≥ 75 Years Versus < 75 Years with VMP in First-Line MM and Bortezomib in Relapsed MM: A084
11. B200 Targeted Drug Combinations in Poor Prognosis Multiple Myeloma: Therapeutic Implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.